During the past decade, Five Towns Neuroscience Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Five Towns Neuroscience Research" are "Brain Infarction" (1 trials), "Cerebral Ischemia" (1 trials), "Epilepsy" (1 trials), "Pain" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Five Towns Neuroscience Research" in a lesser frequency.

Most popular intervention types in "Five Towns Neuroscience Research" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ancrod (Viprinex)" (1 trials), "OraVescent Fentanyl" (1 trials) and "Rufinamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Five Towns Neuroscience Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Five Towns Neuroscience Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Five Towns Neuroscience Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Five Towns Neuroscience Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".